Analytik Jena Increases Stake in Ilmenau-Based ETG to 80.0%
News Apr 12, 2013
Analytik Jena AG has increased its stake in Ilmenau-based ETG Entwicklungs- und Technologie Gesellschaft mbH to 80.0%, thus becoming the largest shareholder.
ETG specializes in the development and assembly of automated sample handling systems for analytical instruments and already generates approximately 85.0% of its sales with Analytik Jena.
Based on the expertise of Analytik Jena, ETG develops and produces almost the entire range of sample storage systems for the Analytical Instrumentation business unit.
These sample storage systems are key accessories for the products of atomic spectroscopy and sum parameters.
ETG possesses very high technological development and production expertise and is to take on further special product developments and their production in the future.
Also related to this is the further concentration of manufacturing resources and expertise at the Ilmenau location.
After the merger of the Berlin-based subsidiary AJ Cybertron in the last financial year and the closure of the Berlin location, which is planned for mid-2013, ETG will take over an essential part of its product portfolio and will continue AJ Cybertron's customer projects in particular.
Analytik Jena's objective is to establish the Ilmenau location as a competence center for automated sample storage systems within the Group in the medium term and thus develop it into an important pillar in the Group-wide manufacturing and production network.
"Based on more than 20 years of device development and on almost as many years of cooperation with Analytik Jena, ETG has a specialized portfolio and excellent production resources for sample handling systems. By increasing our stake, we tie this development expertise and these production capacities more closely to us," said Klaus Berka, CEO of Analytik Jena AG.
ETG was founded in Ilmenau in 1991 and since then has generated profitable results and a positive cash flow.
Analytik Jena has held a 20.0% stake in the Ilmenau-based company since 2002.
Catalyst Can Degrade Alzheimer's-Related Amyloid Peptide Under Near-Infrared LightNews
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Αβ) under near-infrared (NIR) light irradiation has been developed.READ MORE
Understanding 'Disease Mechanisms' of ALSNews
Researchers are making strides in understanding the disease mechanism of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. They recently found that ubiquitin eliminates droplets of Ubiquilin-2 (UBQLN2) in solution. The discovery is noteworthy because UBQLN2 is a protein-encoding gene, mutations to which cause ALS and various types of dementia.READ MORE
A New Class of GlassNews
Lightning and volcanos both produce glass, and humans have been making glass from silicon dioxide since prehistory. Industrialization brought us boron-based glasses, polymer glasses and metallic glasses, but now an international team of researchers has developed a new family of glass based on metals and organic compounds that stacks up to the original silica in glass-forming ability.READ MORE
Comments | 0 ADD COMMENT
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018